跳至主要内容
临床试验/CTRI/2018/02/011675
CTRI/2018/02/011675已完成Unknown

Effectiveness of Herbal and 0.12% Chlorhexidine mouthwash on Gingivitis and Salivary Neutrophils Count.

Shweta Sharda1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2016年12月8日最近更新:

试验速览

阶段
Unknown
状态
已完成
发起方
入组人数
32
试验地点
1
主要终点
Gingivitis - measured by Modified Loe and Silness Gingival index

研究概览

简要总结

Background and Aim: Use of mouthwashes as an adjunct in the daily oralhygiene regimen has been strongly recommended by the dentists worldwide.Chlorhexidine has in fact been proven to be a gold standard in mouthwashes andis known to significantly reduce/prevent gingivitis. But owing to itsside-effects of tooth discoloration and transient taste alteration on its longterm use, there has been a constant effort to discover an equally efficientmouthwash with minimal or no side-effects. The aim of this study was toevaluate the effectiveness of a commercially available herbal mouthwash(Himalaya HiOra Regular) in comparison to 0.12% Chlorhexidine mouthwash inreducing gingivitis and salivary neutrophil count.

Methods and Materials: This study was a double blinded, randomized design.The herbal mouthwash (Himalaya HiOra Regular) was compared to 0.12%Chlorhexidine mouthwash (positive control).The patients gingival health statuswas evaluated using Gingival Index and Salivary Neutrophil Count (usingFluorescent Microscope) at baseline visit, 15th day and 30thday of intervention.

Results: Outof the 36 subjects randomized, none were lost to follow up and a total of  18 were analysed in Group A(Himalaya HiOraRegular Mouthwash) and 18 in Group B(0.12% Chlorhexidine). Both the groupsshowed a statistically significant reduction in Gingival Index Score ( Group A - 17%   & Group B - 14%   ) and in Salivary Neutrophil Counts (GroupA -  35%  & Group B -32%). There was no significant difference inbetween the two groups both in the Gingival Scores ( ) and in the salivaryneutrophil counts (  ).

Conclusions: Thisstudy has shown that herbal mouthwash is at par with the gold standard  in reducing gingivitis in a 4 week period.Thus herbal mouthwash forms a promising adjunct to the daily oral hygieneregimen with minimal/ no side effects reported.

研究设计

研究类型
Interventional
分配方式
Adaptive randomization, such as minimization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 49.00 Year(s)(—)
性别
All

入选标准

  • 1.A minimum of 20 sound natural teeth with scorable facial and lingual surfaces.
  • 2.Willingness to read, understand and sign the informed consent form.
  • 3.Male and female subjects between 18-50 years in good general health.
  • 4.Subject with good periodontal health with pockets < 6mm.
  • 5.A gingival index score of ≥1.
  • 6.A plaque index score of ≥1.
  • 7.Availability for the entire study duration.

排除标准

  • 1.Destructive periodontal disease.
  • 2.Significant soft tissue pathology, systemically related gingival enlargement / severe gingivitis.
  • 3.History of diabetes, hepatic, renal disease or other serious medical condition and transmissible disease.
  • 4.Orthodontic appliance or any kind of fixed or removable appliances.
  • Materials & Methods 5.History of allergies to dental products or their ingredients.
  • 6.Pregnant and breast feeding women.
  • 7.History of adverse habits like smoking and tobacco chewing.
  • 8.Undergoing antibiotic, steroid therapy or any anti-inflammatory drugs in the preceding month.

结局指标

主要结局

Gingivitis - measured by Modified Loe and Silness Gingival index

时间窗: 15th day and 30th day post intervention

次要结局

  • Salivary Neutrophil Count(15th day and 30th day post intervention)

研究者

发起方
Shweta Sharda
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验

已完成
不适用
Clinical Trial to compare the effectiveness of Chlorhexidine at lower concentrations for Pneumonia development in ventilator assisted patients
CTRI/2019/05/019116Dr Nagesh Vyas113
已完成
1 期
Oral Care Interventions and Ventilator Associated Pneumonia in Critically Ill ChildrenVentilator Associated Pneumonia
NCT01083407Federal University of São Paulo146
进行中(未招募)
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.Prevention of alveolar osteitis after third molar extractionMedDRA version: 18.0 Level: PT Classification code 10066995 Term: Alveolar osteitis System Organ Class: 10021881 - Infections and infestations
EUCTR2014-004682-24-FRPIERRE FABRE MEDICAMENT409
进行中(未招募)
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.
EUCTR2014-004682-24-EEInstitut de Recherche Pierre Fabre - Centre de R&D Pierre Fabre414
进行中(未招募)
1 期
Efficacy of DC071 mouthwash (0,2 % chlorhexidine digluconate) in peri-surgical care for preventing alveolar osteitis after third molar extraction.Prevention of alveolar osteitis after third molar extractionMedDRA version: 18.1Level: PTClassification code 10066995Term: Alveolar osteitisSystem Organ Class: 10021881 - Infections and infestations
EUCTR2014-004682-24-LTInstitut de Recherche Pierre Fabre - Centre de R&D Pierre Fabre414